We are live on ! Find out more
CALA

Calithera Biosciences, Inc
CALA

Delisted

CALA was delisted on the 1st of February, 2023.

Back to rankings

1 hedge funds and large institutions have $3.92K invested in Calithera Biosciences, Inc in 2023 Q2 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more capital invested

Capital invested by funds: $3.92K → $3.92K ($0)

50% less funds holding

Funds holding: 2 → 1 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
FCA
1
FinTrust Capital Advisors
South Carolina
$3.92K – – –

CALA Hedge Fund Activity: Q2 2023 in Review

1 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q2 2023, worth a combined $3.92K — unchanged from a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CALA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

  • 1 institutional investor held Calithera Biosciences, Inc (CALA) as of Q2 2023, down from 2 in Q1 2023.
  • Funds reported $3.92K of Calithera Biosciences, Inc stock for Q2 2023, unchanged quarter-over-quarter.
  • 0 funds opened new Calithera Biosciences, Inc positions in Q2 2023 and 1 closed out, a net change of -1 holder.

Based on aggregated 13F filings for Q2 2023.